ERA-based diagnostic assay for rapid detection of respiratory syncytial virus. Provides accurate identification of RSV infections in respiratory specimens.
Manufactured by
Suzhou, Jiangsu, China
In 2007, GenDxbio was founded, which marked the company's initial stage. In 2017, GenDx Biotech was established and acquired GenDxbio in the same year. GenDx Biotech is committed to on-spot pathogens detection solutions with the molecular Point-of-Care Testing (POCT) technology platforms and the comprehensive instrument systems. Over the past two decades, ERA Technology (Enzymatic Rapid Amplification) and GENEYE ® systems developed by GenDx Biotech have been highly recongnized as a preferred solution for various pathogens identification in kinds of scenarios.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
Credo Diagnostics Biomedical Pte. Ltd.
Singapore · 2 relevant products
Adaltis Srl
Italy · 1 relevant product
54 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 96 closest product alternatives
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for respiratory syncytial virus detection. Provides reliable and accurate identification of RSV infections with strong analytical performance.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A rapid and accurate Point-of-Care diagnostic test for influenza and RSV detection. It enables multiplex respiratory viral testing at the point-of-care. Available variants: VitaPCR™ Flu/RSV Assay.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
Rapid molecular diagnostic assay for simultaneous detection of SARS-CoV-2, influenza, and RSV. Delivers real-time PCR results in 20 minutes from sample collection, enabling point-of-care testing and immediate clinical decision-making. Designed for deployment in clinical settings to reduce turnaround time and diagnostic costs.
93 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products